Skip to Content

CM4 (Invokamet XR canagliflozin 150 mg / metformin hydrochloride extended-release 1000 mg)

Generic Name: canagliflozin/metformin

Pill with imprint CM4 is Brown, Capsule-shape and has been identified as Invokamet XR canagliflozin 150 mg / metformin hydrochloride extended-release 1000 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Invokamet XR is used in the treatment of cardiovascular risk reduction; diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Invokamet XR canagliflozin 150 mg / metformin hydrochloride extended-release 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CM4

Invokamet XR canagliflozin 150 mg / metformin hydrochloride extended-release 1000 mg CM4

Invokamet XR

Generic Name
canagliflozin/metformin
Imprint
CM4
Strength
canagliflozin 150 mg / metformin hydrochloride extended-release 1000 mg
Color
Brown
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC)
50458-0943
Inactive Ingredients
croscarmellose sodium, lactose anhydrous, magnesium stearate, microcrystalline cellulose, magnesium silicate, titanium dioxide, ferric oxide red, ferric oxide yellow, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.